School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia
- Conditions
- Familial Hyperlipidemia
- Registration Number
- NCT05767996
- Lead Sponsor
- Poudre Valley Health System
- Brief Summary
Determination of FH status by genetic testing in school age children who have demonstrated elevated cholesterol on baseline screening.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
Elevated cholesterol on baseline screening to use as means of identifying those with an FH variant
Exclusion Criteria
- normal cholesterol
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia Evaluation of family members over a defined 5 year period Percentage of school children who have elevated cholesterol related to FH variant
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic markers are used in FH diagnosis in NCT05767996's pediatric screening program?
How effective is school-based lipid screening compared to family history in identifying FH in children?
Which biomarkers predict FH in children with elevated cholesterol in this trial?
What are the long-term cardiovascular outcomes for children identified with FH through this program?
How does early detection via this program influence the use of statins or PCSK9 inhibitors in FH management?
Trial Locations
- Locations (1)
Medical Center of the Rockies
🇺🇸Loveland, Colorado, United States
Medical Center of the Rockies🇺🇸Loveland, Colorado, United States